Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CPNASDAQ:DVAXNASDAQ:DXCMNYSE:HESNYSE:KSUNASDAQ:RGNXNYSE:TRU On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCPCanadian Pacific Kansas City$79.65-1.7%$79.13$66.49▼$87.72$74.66B1.072.81 million shs1.55 million shsDVAXDynavax Technologies$10.30+0.3%$10.12$9.22▼$14.63$1.23B1.032.16 million shs1.84 million shsDXCMDexCom$82.94+0.0%$83.26$57.52▼$117.19$32.52B1.444.41 million shs2.78 million shsHESHess$143.30-0.5%$135.88$123.79▼$161.69$44.55B0.621.81 million shs2.92 million shsKSUKansas City Southern$293.59$297.85$190.64▼$315.39$26.71B1.11.25 million shs40.68 million shsRGNXREGENXBIO$8.43-3.5%$8.98$5.04▼$15.36$438.40M1.06929,241 shs679,975 shsTRUTransUnion$91.55-0.1%$86.95$66.38▼$113.17$17.87B1.631.79 million shs1.49 million shs10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCPCanadian Pacific Kansas City0.00%+3.56%-0.94%+18.32%+1.11%DVAXDynavax Technologies0.00%+3.73%+0.39%-17.69%-8.62%DXCMDexCom0.00%-4.17%-4.55%+34.24%-27.23%HESHess0.00%+2.41%+4.73%+9.25%-3.04%KSUKansas City Southern0.00%0.00%0.00%0.00%0.00%RGNXREGENXBIO0.00%+4.05%-9.16%+47.22%-19.91%TRUTransUnion0.00%+5.31%+6.28%+29.80%+20.14%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCPCanadian Pacific Kansas City4.2849 of 5 stars3.33.01.70.64.01.71.3DVAXDynavax Technologies4.3785 of 5 stars3.32.00.04.72.01.71.9DXCMDexCom4.8942 of 5 stars3.55.00.04.72.92.51.9HESHess4.8688 of 5 stars3.34.02.51.22.62.53.1KSUKansas City SouthernN/AN/AN/AN/AN/AN/AN/AN/ARGNXREGENXBIO4.4642 of 5 stars3.43.00.04.62.13.30.6TRUTransUnion4.5745 of 5 stars2.35.01.74.42.80.81.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCPCanadian Pacific Kansas City 2.63Moderate Buy$90.9514.18% UpsideDVAXDynavax Technologies 2.50Moderate Buy$24.00133.01% UpsideDXCMDexCom 2.95Moderate Buy$98.5018.76% UpsideHESHess 2.55Moderate Buy$162.8613.65% UpsideKSUKansas City Southern 0.00N/AN/AN/ARGNXREGENXBIO 2.83Moderate Buy$31.63275.15% UpsideTRUTransUnion 2.57Moderate Buy$109.6919.82% UpsideCurrent Analyst Ratings BreakdownLatest TRU, CP, DVAX, HES, DXCM, RGNX, and KSU Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/2/2025HESHessPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$147.00 ➝ $153.006/26/2025HESHessWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$193.00 ➝ $184.006/24/2025CPCanadian Pacific Kansas CitySusquehannaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingPositive ➝ Positive$90.00 ➝ $94.006/16/2025DXCMDexComTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$102.006/11/2025HESHessUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$163.00 ➝ $173.006/9/2025RGNXREGENXBIOChardan CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$52.006/2/2025CPCanadian Pacific Kansas CityThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Neutral$91.005/30/2025DXCMDexComThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$104.005/22/2025DXCMDexComCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$82.00 ➝ $102.005/22/2025TRUTransUnionOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$96.00 ➝ $100.005/16/2025CPCanadian Pacific Kansas CityBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$82.00 ➝ $90.00(Data available from 7/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCPCanadian Pacific Kansas City$10.62B6.91$4.51 per share17.66$38.22 per share2.08DVAXDynavax Technologies$277.25M4.46$0.16 per share64.86$4.54 per share2.27DXCMDexCom$4.03B8.06$2.25 per share36.90$5.38 per share15.42HESHess$13.02B3.40$17.67 per share8.11$38.96 per share3.68KSUKansas City Southern$2.63B10.15$10.98 per share26.74$48.19 per share6.09RGNXREGENXBIO$83.33M5.07N/AN/A$5.24 per share1.61TRUTransUnion$4.18B4.27$6.22 per share14.71$22.16 per share4.13Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCPCanadian Pacific Kansas City$2.71B$2.9625.6420.272.2725.99%8.68%4.79%7/29/2025 (Estimated)DVAXDynavax Technologies$27.31M-$0.5273.3621.02N/A-20.39%3.59%2.20%8/5/2025 (Estimated)DXCMDexCom$576.20M$1.3450.2633.721.7712.90%30.05%10.00%7/30/2025 (Estimated)HESHess$2.77B$7.2317.2912.46N/A17.65%21.78%9.72%7/30/2025 (Estimated)KSUKansas City Southern$617M$1.02287.8430.17N/A3.33%16.69%7.02%N/ARGNXREGENXBIO-$227.10M-$3.11N/AN/AN/A-100.62%-53.29%-30.84%8/7/2025 (Estimated)TRUTransUnion$284.30M$1.8825.6619.032.538.63%16.18%6.38%7/24/2025 (Estimated)Latest TRU, CP, DVAX, HES, DXCM, RGNX, and KSU EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/30/2025Q2 2025DXCMDexCom$0.45N/AN/AN/A$1.13 billionN/A7/30/2025Q2 2025HESHess$1.22N/AN/AN/A$2.69 billionN/A7/29/2025Q2 2025CPCanadian Pacific Kansas City$0.82N/AN/AN/A$2.76 billionN/A7/24/2025Q2 2025TRUTransUnion$0.99N/AN/AN/A$1.10 billionN/A5/12/2025Q1 2025RGNXREGENXBIO$0.41$0.12-$0.29$0.12$105.35 million$89.01 million5/6/2025Q1 2025DVAXDynavax Technologies$0.03-$0.11-$0.14-$0.77$70.01 million$68.16 million5/1/2025Q1 2025DXCMDexCom$0.33$0.32-$0.01$0.27$1.02 billion$1.04 billion4/30/2025Q1 2025CPCanadian Pacific Kansas City$0.74$0.74N/A$0.68$2.56 billion$2.66 billion4/30/2025Q1 2025HESHess$1.95$1.81-$0.14$1.39$2.95 billion$2.92 billion4/24/2025Q1 2025TRUTransUnion$0.98$1.05+$0.07$0.75$1.07 billion$1.10 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCPCanadian Pacific Kansas City$0.660.83%N/A22.30%N/ADVAXDynavax TechnologiesN/AN/AN/AN/AN/ADXCMDexComN/AN/AN/AN/AN/AHESHess$2.001.40%N/A27.66%3 YearsKSUKansas City Southern$2.160.74%N/A211.77%N/ARGNXREGENXBION/AN/AN/AN/AN/ATRUTransUnion$0.460.50%N/A24.47%1 YearsLatest TRU, CP, DVAX, HES, DXCM, RGNX, and KSU DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/30/2025CPCanadian Pacific Kansas Cityquarterly$0.16440.8%6/27/20256/27/20257/28/20255/14/2025HESHessquarterly$0.501.49%6/16/20256/16/20256/30/20255/8/2025TRUTransUnionquarterly$0.11500.54%5/22/20255/22/20256/6/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCPCanadian Pacific Kansas City0.430.810.70DVAXDynavax Technologies0.4911.9310.84DXCMDexCom0.551.501.32HESHess0.711.080.91KSUKansas City Southern0.890.720.62RGNXREGENXBION/A2.932.93TRUTransUnion1.132.052.05Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCPCanadian Pacific Kansas City72.20%DVAXDynavax Technologies96.96%DXCMDexCom97.75%HESHess88.51%KSUKansas City Southern79.69%RGNXREGENXBIO88.08%TRUTransUnionN/AInsider OwnershipCompanyInsider OwnershipCPCanadian Pacific Kansas City0.01%DVAXDynavax Technologies2.98%DXCMDexCom0.32%HESHess9.10%KSUKansas City Southern0.83%RGNXREGENXBIO12.79%TRUTransUnion0.25%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCPCanadian Pacific Kansas City19,797921.41 million921.32 millionOptionableDVAXDynavax Technologies350120.08 million116.50 millionOptionableDXCMDexCom10,300392.11 million390.85 millionOptionableHESHess1,797309.31 million281.16 millionOptionableKSUKansas City Southern6,52290.98 million90.23 millionOptionableRGNXREGENXBIO37050.16 million43.75 millionOptionableTRUTransUnion13,400195.10 million194.61 millionOptionableTRU, CP, DVAX, HES, DXCM, RGNX, and KSU HeadlinesRecent News About These CompaniesTransUnion Q2 Preview: Continue Growing Amid Subdued Credit Market; Initiate With 'Buy'July 7 at 10:37 AM | seekingalpha.comStudy: Filipinos cut back, save more amid inflationJuly 7 at 5:37 AM | sunstar.com.phSFinanciere des Professionnels Fonds d investissement inc. Buys 32,668 Shares of TransUnion (NYSE:TRU)July 6 at 9:17 AM | marketbeat.comTransUnion (NYSE:TRU) Shares Sold by Wealth Enhancement Advisory Services LLCJuly 5 at 3:21 AM | marketbeat.comTransUnion (NYSE:TRU) Rating Increased to Buy at Wall Street ZenJuly 5 at 2:40 AM | americanbankingnews.comTransUnion (NYSE:TRU) Upgraded by Wall Street Zen to "Buy" RatingJuly 5 at 2:37 AM | marketbeat.comCannon Global Investment Management LLC Purchases Shares of 2,900 TransUnion (NYSE:TRU)July 3, 2025 | marketbeat.comSumitomo Mitsui Trust Group Inc. Has $36.43 Million Stock Holdings in TransUnion (NYSE:TRU)July 3, 2025 | marketbeat.comCautious optimism prevails as Filipino consumers navigate economic pressuresJuly 3, 2025 | mindanaotimes.com.phMInsider Selling: TransUnion (NYSE:TRU) Insider Sells 1,000 Shares of StockJuly 2, 2025 | marketbeat.comWilson Asset Management International PTY Ltd. Purchases 6,515 Shares of TransUnion (NYSE:TRU)July 2, 2025 | marketbeat.comKBC Group NV Lowers Position in TransUnion (NYSE:TRU)July 1, 2025 | marketbeat.comAllspring Global Investments Holdings LLC Buys 39,481 Shares of TransUnion (NYSE:TRU)July 1, 2025 | marketbeat.comAsset Management One Co. Ltd. Has $6.01 Million Stock Position in TransUnion (NYSE:TRU)June 29, 2025 | marketbeat.comTransUnion (NYSE:TRU) Shares Bought by Marathon Asset Management LtdJune 28, 2025 | marketbeat.comTransUnion (NYSE:TRU) Shares Sold by Copeland Capital Management LLCJune 28, 2025 | marketbeat.comRobeco Institutional Asset Management B.V. Has $23.82 Million Stock Holdings in TransUnion (NYSE:TRU)June 28, 2025 | marketbeat.comTransUnion Report Reveals Number of Consumers Delinquent on Student Loans and At Risk for Default Is RisingJune 27, 2025 | crowdfundinsider.comCTransUnion Announces Earnings Release Date for Second Quarter 2025 Results | TRU Stock NewsJune 27, 2025 | gurufocus.comTransUnion to Announce Second Quarter Financial Results on July 24, 2025June 27, 2025 | quiverquant.comQTransUnion Announces Earnings Release Date for Second Quarter 2025 ResultsJune 27, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Semiconductor Stocks Poised to Surge on AI SpendingBy Chris Markoch | June 25, 2025View 3 Semiconductor Stocks Poised to Surge on AI Spending3 AI Infrastructure Stocks With Strong Growth, Not HypeBy Chris Markoch | June 26, 2025View 3 AI Infrastructure Stocks With Strong Growth, Not HypeDon’t Miss These 2 Small Quantum Stocks Poised to PopBy Gabriel Osorio-Mazilli | June 24, 2025View Don’t Miss These 2 Small Quantum Stocks Poised to PopApplied Digital: Now the High-Stakes Race to Build BeginsBy Jeffrey Neal Johnson | June 17, 2025View Applied Digital: Now the High-Stakes Race to Build BeginsWhy Goldman Sachs Suddenly Boosted These 3 Trucking StocksBy Gabriel Osorio-Mazilli | June 9, 2025View Why Goldman Sachs Suddenly Boosted These 3 Trucking StocksTRU, CP, DVAX, HES, DXCM, RGNX, and KSU Company DescriptionsCanadian Pacific Kansas City NYSE:CP$79.65 -1.38 (-1.70%) Closing price 03:58 PM EasternExtended Trading$79.66 +0.00 (+0.01%) As of 05:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Canadian Pacific Kansas City Limited, together with its subsidiaries, owns and operates a transcontinental freight railway in Canada, the United States, and Mexico. The company transports bulk commodities, including grain, coal, potash, fertilizers, and sulphur; merchandise freight, such as forest products, energy, chemicals and plastics, metals, minerals, consumer products, and automotive; and intermodal traffic comprising retail goods in overseas containers. It also provides rail and intermodal transportation services over a network of approximately 20,000 miles serving business centres. The company was formerly known as Canadian Pacific Railway Limited and changed its name to Canadian Pacific Kansas City Limited in April 2023. Canadian Pacific Kansas City Limited was incorporated in 1881 and is headquartered in Calgary, Canada.Dynavax Technologies NASDAQ:DVAX$10.30 +0.03 (+0.29%) Closing price 04:00 PM EasternExtended Trading$10.30 +0.00 (+0.05%) As of 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. The company was incorporated in 1996 and is headquartered in Emeryville, California.DexCom NASDAQ:DXCM$82.94 +0.01 (+0.01%) Closing price 04:00 PM EasternExtended Trading$82.68 -0.25 (-0.31%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.Hess NYSE:HES$143.30 -0.73 (-0.51%) Closing price 03:58 PM EasternExtended Trading$142.25 -1.05 (-0.73%) As of 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Hess Corporation, an exploration and production company, explores, develops, produces, purchases, transports, and sells crude oil, natural gas liquids (NGLs), and natural gas. The company operates in two segments, Exploration and Production, and Midstream. It conducts production operations primarily in the United States, Guyana, the Malaysia/Thailand Joint Development Area, and Malaysia; and exploration activities principally offshore Guyana, the U.S. Gulf of Mexico, and offshore Suriname and Canada. The company is also involved in gathering, compressing, and processing natural gas; fractionating NGLs; gathering, terminaling, loading, and transporting crude oil and NGL through rail car; and storing and terminaling propane, as well as providing water handling services primarily in the Bakken Shale plays in the Williston Basin area of North Dakota. The company was incorporated in 1920 and is headquartered in New York, New York.Kansas City Southern NYSE:KSUKansas City Southern is a transportation holding company. It focuses on the growing north or south freight corridor connecting key commercial and industrial markets in the central United States with major industrial cities in Mexico. The firm also engages in the freight rail transportation business operating through a single coordinated rail network. The company was founded by Arthur E. Stilwell in 1887 and is headquartered in Kansas City, MO.REGENXBIO NASDAQ:RGNX$8.43 -0.31 (-3.55%) As of 04:00 PM EasternREGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's products in pipeline includes ABBV-RGX-314 for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other chronic retinal diseases; and RGX-202, which is in Phase I/II clinical trial for the treatment of Duchenne muscular dystrophy. It also develops RGX-121 for the treatment of mucopolysaccharidosis type II that is in Phase III clinical trial; RGX-111 for treating mucopolysaccharidosis type I; RGX-181 for the treatment of late infantile neuronal ceroid lipofuscinosis type II; and RGX-381 to treat the ocular manifestations of CLN2 disease. In addition, the company licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies. Further, it has a collaboration and license agreement with AbbVie Global Enterprises Ltd. to develop ABBV-RGX-314 outside the United States. REGENXBIO Inc. was incorporated in 2008 and is headquartered in Rockville, Maryland.TransUnion NYSE:TRU$91.55 -0.06 (-0.07%) Closing price 03:58 PM EasternExtended Trading$91.40 -0.15 (-0.16%) As of 07:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.TransUnion operates as a global consumer credit reporting agency that provides risk and information solutions. The company operates through U.S. Markets, International, and Consumer Interactive segments. The U.S. Markets segment provides consumer reports, actionable insights, and analytic services to businesses, which uses its services to acquire new customers; assess consumer ability to pay for services; identify cross-selling opportunities; measure and manage debt portfolio risk; collect debt; verify consumer identities; and mitigate fraud risk. This segment serves various industry vertical markets, including financial services, technology, commerce and communications, insurance, media, services and collections, tenant and employment, and public sectors. The International segment offers credit reports, analytics, technology solutions, and other value-added risk management services; consumer services, which help consumers to manage their personal finances; consumer credit reporting, insurance and auto information solutions, and commercial credit information services. It serves customers in financial services, retail credit, insurance, automotive, collections, public sector, and communications industries through direct and indirect channels. The company was formerly known as TransUnion Holding Company, Inc. and changed its name to TransUnion in March 2015. TransUnion was founded in 1968 and is headquartered in Chicago, Illinois. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas CoreWeave's $9 Billion Power Play for Core Scientific Micron Insiders Sell But Investors Should Buy, Buy, Buy Could Dutch Bros Dethrone Starbucks? Why Investors Are Perking Up ExxonMobil: Limited Risk and Lots of Reward With This Oil Play D-Wave Is Rising Again Despite Dilution—What’s the Deal? Datadog Joins S&P 500, Triggering a New Wave of Upside MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
